Opioid Addiction News and Research

RSS
Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses

Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses

BMC partners with RIH, CVS to support pharmacy-based naloxone rescue kits to help combat opioid addiction, overdose

BMC partners with RIH, CVS to support pharmacy-based naloxone rescue kits to help combat opioid addiction, overdose

New research looks at quickly expanding effort to equip law enforcement officers with naloxone

New research looks at quickly expanding effort to equip law enforcement officers with naloxone

Braeburn reports positive topline results from Probuphine Phase 3 study for treatment of opioid addiction

Braeburn reports positive topline results from Probuphine Phase 3 study for treatment of opioid addiction

BioDelivery Sciences calls for new treatment options for opioid addiction

BioDelivery Sciences calls for new treatment options for opioid addiction

Study provides new estimates of opioid misuse, addiction

Study provides new estimates of opioid misuse, addiction

Policymakers need to look beyond painkiller abuse to reduce opioid overdose deaths, say researchers

Policymakers need to look beyond painkiller abuse to reduce opioid overdose deaths, say researchers

Study findings could offer roadmap for preventing deaths from drug overdoses

Study findings could offer roadmap for preventing deaths from drug overdoses

Month-long residential program helps young adults stay drug-free

Month-long residential program helps young adults stay drug-free

DEA announces that unused prescription pills can be returned to pharmacies

DEA announces that unused prescription pills can be returned to pharmacies

Low dose of opioids including methadone effective for treatment of testosterone suppression

Low dose of opioids including methadone effective for treatment of testosterone suppression

State highlights: Time of turmoil for Georgia hospitals; Oregon Medicaid takes aim at expensive heptatitis C drug

State highlights: Time of turmoil for Georgia hospitals; Oregon Medicaid takes aim at expensive heptatitis C drug

Naltrexone may be effective in diminishing ICD symptoms in PD patients, study finds

Naltrexone may be effective in diminishing ICD symptoms in PD patients, study finds

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

HHS calls health care providers to expand use of medications to treat opioid addiction, reduce overdose deaths

HHS calls health care providers to expand use of medications to treat opioid addiction, reduce overdose deaths

Methadone safety: New clinical practice guideline from American Pain Society

Methadone safety: New clinical practice guideline from American Pain Society

Researcher develops novel IBT to help opioid-dependent Vermonters

Researcher develops novel IBT to help opioid-dependent Vermonters

Study shows important parallels between epidemic of HIV/AIDS and opioid addiction

Study shows important parallels between epidemic of HIV/AIDS and opioid addiction

Opiate use alters activity of specific protein needed for normal functioning of brain's reward center

Opiate use alters activity of specific protein needed for normal functioning of brain's reward center

FSMB joins with partners to educate health care professionals on safe prescribing of opioid analgesics

FSMB joins with partners to educate health care professionals on safe prescribing of opioid analgesics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.